- Global Pharma News & Resources

Press Releases - 2022-12-12

Date Title Company
12-Dec-2022 Fibrin Degradation Product (FnDP) Assays Positioning and Growing Market Share Worldwide MARKITWIRED
12-Dec-2022 Medical Physics Market Growth, Regional Analysis, Trends and Forecast 2022-2028 MARKITWIRED
12-Dec-2022 MRI Pulse Oximeters Projected to Gain Significant Value through 2022-2028 MARKITWIRED
12-Dec-2022 Corneal Ulcers Treatment Market Segment Overview, Regional Analysis and Forecast 2022-2029 MARKITWIRED
12-Dec-2022 Dual and Multi-Energy Computed Tomography Market expected to See Incredible Growth By 2029 MARKITWIRED
12-Dec-2022 DeciBio Consulting Adds Steve Beuchaw as a Partner, Establishing a New York Presence Businesswire
12-Dec-2022 The Worldwide Industrial Workwear Industry is Expected to Reach $51 Billion by 2027 - Businesswire
12-Dec-2022 Global Rare Disease Drugs Market Report 2022: A $147.12 Billion Market in 2021 - Analysis By Drug Type, Therapeutic Area, Patients, Route of Administration, Distribution Channel - Businesswire
12-Dec-2022 Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting Businesswire
12-Dec-2022 Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 Businesswire
12-Dec-2022 Genentech Presents New Data Demonstrating the Potential of Glofitamab and Mosunetuzumab as Fixed-Duration, Off-The-Shelf Treatment Options for Lymphoma Businesswire
12-Dec-2022 Gilead Sciences Again Named to Dow Jones Sustainability World Index Businesswire
12-Dec-2022 Global Medical Tubing Market Report 2022 to 2030 - Featuring Avient, Saint-Gobain, Hitachi and Microlumen Among Others - Businesswire
12-Dec-2022 Global Epilepsy Drug Market (2022-2027): Rising Drug Approvals of Anticonvulsant Drugs from Regulatory Bodies Presents Opportunities - Businesswire
12-Dec-2022 Asher Bio Presents New Preclinical Data at ASH Applying Cis-Targeted Cytokines to Enhance CAR-T Cell Therapies Businesswire
12-Dec-2022 Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual Meeting Businesswire
12-Dec-2022 Seagen Announces Results from Phase 2 Clinical Trial of ADCETRIS® (brentuximab vedotin) with Novel Immunotherapy Combination in Patients with Advanced- and Early-Stage Classical Hodgkin Lymphoma Businesswire
12-Dec-2022 New Ropeginterferon alfa-2b Data Show Importance of Proactive Care Earlier in the Polycythemia Vera Patient Journey Businesswire
12-Dec-2022 Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022 Businesswire
12-Dec-2022 Electra Therapeutics highlights ELA026 Phase 1b study in sHLH and presents preclinical data at ASH Annual Meeting Businesswire